IRONWOOD PHARMACEUTICALS INC·4

Aug 16, 4:20 PM ET

John Minardo 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Aug 16, 2023

Insider Transaction Report

Form 4
Period: 2023-08-14
John Minardo
Chief Legal Officer
Transactions
  • Sale

    Class A Common Stock

    2023-08-14$10.04/sh7,045$70,732192,195 total
Footnotes (1)
  • [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION